Colcemide - CAS 477-30-5

Colcemide - CAS 477-30-5 Catalog number: BADC-00179

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

An antineoplastic alkaloid from Colchicum autumnale L. isolated from Colchicum autumnale L.

Category
ADCs Cytotoxin
Product Name
Colcemide
CAS
477-30-5
Catalog Number
BADC-00179
Molecular Formula
C21H25NO5
Molecular Weight
371.43
Purity
≥98% ( HPLC)
Colcemide

Ordering Information

Catalog Number Size Price Quantity
BADC-00179 -- $-- Inquiry
Description
An antineoplastic alkaloid from Colchicum autumnale L. isolated from Colchicum autumnale L.
Synonyms
Demecolcine; colcemid; (-)-Demecolcine; Colchamine; Demecolcin; Reichstein's F; Colcemide; Desmecolcine; Substance F; Santavy's substance F; (-)-Colchamine; Kolchamin; Kolkamin; Omain; Omaine; Methylcolchicine; N-Deacetyl-N-methylcolchicine; N-Methyl-N-deacetylcolchicine; Deacetylmethylcolchicine; N-Desacetyl-N-methylcolchicine; N-Methyl-N-desacetylcolchicine; Desacetylmethylcolchicine; Demecolcina; Demecolcinum; Deacetyl-N-methylcolchicine; Kolchicin; N-Desacetylmethylcolchicine; Colchicine, N-deacetyl-N-methyl-; (S)-1,2,3,10-Tetramethoxy-7-(methylamino)-6,7-dihydrobenzo[a]heptalen-9(5H)-one; Colchamin
IUPAC Name
(7S)-1,2,3,10-tetramethoxy-7-(methylamino)-6,7-dihydro-5H-benzo[a]heptalen-9-one
Canonical SMILES
CNC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
InChI
InChI=1S/C21H25NO5/c1-22-15-8-6-12-10-18(25-3)20(26-4)21(27-5)19(12)13-7-9-17(24-2)16(23)11-14(13)15/h7,9-11,15,22H,6,8H2,1-5H3/t15-/m0/s1
InChIKey
NNJPGOLRFBJNIW-HNNXBMFYSA-N
Melting Point
73-75°C
LogP
1.37
Appearance
Crystalline powder
Shipping
Room temperature
Storage
Store at room temperature.
In Vivo
The increased cell size in response to SP600125 was detected even in P19 cells treated with colcemide, an inhibitor of cell cycle progression at the metaphase. C-metaphase plates were obtained from the bone marrow lymphocytes synchronized by the addition of 0.25 microg/ml colcemide. No significant difference in chromosomal aneuploidy between transgenic (61%) and non-transgenic (51.27%) rabbits of line I was observed.
1. Effect of cadmium and colcemide on the mitoses of a human epithelial cell line with high content of cytoplasmic metallothionein
A Bakka, V Digernes Acta Pharmacol Toxicol (Copenh) . 1984 Sep;55(3):242-6. doi: 10.1111/j.1600-0773.1984.tb02044.x.
Cultures of cell strains with and without metallothionein were exposed to CdCl2 in doses ranging from 10 mu mol/l to 200 mu mol/l . Cell growth parameters were monitored by flow cytometric DNA-measurements, cell counts and counting of mitoses during the first two days after exposure. CdCl2 inhibited cell growth in a dose dependent way. The cadmium resistant cells were inhibited with concentrations above 100 mu mol/l, the concentration which the metallothionein-containing cells had previously been adjusted to. Microscopy of the cell cultures showed a dose dependent accumulation of cells in the mitotic prophase, whereas the other phases of the cell cycle were unaffected as measured by flow cytometry. When exposed to colcemide, however, the two cell strains showed identical responsiveness.
2. LIFE CYCLE ANALYSIS OF MAMMALIAN CELLS. I. A METHOD FOR LOCALIZING METABOLIC EVENTS WITHIN THE LIFE CYCLE, AND ITS APPLICATION TO THE ACTION OF COLCEMIDE AND SUBLETHAL DOSES OF X-IRRADIATION
J STEFFEN, T T PUCK Biophys J . 1963 Sep;3(5):379-97. doi: 10.1016/s0006-3495(63)86828-9.
Equations are presented describing the accumulation of cells at any part of the life cycle as a result of addition of specific blocking agents. An experimental methodology using these relationships is described which makes possible analysis with relatively high resolution of the distribution of cells throughout the life cycle in normal cultures or those treated with various agents. The action of colcemide on S3 HeLa cells studied by this method revealed that colcemide has no effect on the G1, S, or G2 stages; it blocks cells quantitatively at the metaphase-anaphase region; but it accumulates mitotic figures only from the cells which have not yet entered mitosis at the time of its addition. The technique was also applied to study the efficiency of x-irradiation in delaying the entrance of G2 cells into mitosis. A definite lag was found at the lowest dose studied which was 9 rads. Only the cells confined to a central region of G2 at the time of irradiation are affected by this dose.
3. Sister chromatid exchange
Jeremy A Squire, Jane Bayani Curr Protoc Cell Biol . 2005 Jan;Chapter 22:Unit 22.7. doi: 10.1002/0471143030.cb2207s25.
Sister chromatid exchange (SCE) refers to the interchange of DNA between replication products. The technique for detecting such exchanges takes advantage of the semiconservative nature of DNA synthesis. 5'-bromodeoxyuridine (BrdU) is incorporated into the newly synthesized DNA. Using standard culturing techniques, Colcemid is added to the culture and conventional cytogenetic preparations are made. Differential staining with Hoechst dye and Giemsa allows the newly synthesized DNA within a chromatid to be recognized, since BrdU incorporation results in much weaker staining. SCEs represent a point of DNA template exchange during strand synthesis, visualized as asymmetric chromatid staining or "harlequin" chromosomes.
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Colcemide
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket